Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Urinary Bladder Neoplasms ×

Clinical Trial (67)
Neoplasms (25)
Eligibility Determination (13)
Treatment Form (11)
Follow-Up Studies (10)
Registration (8)
Urology (7)
On-Study Form (7)
Registries (4)
Laboratories (3)
Adverse event (2)
Death (2)
Medical History Taking (2)
Pathology (2)
Postoperative Period (1)
Questionnaires (1)
Thromboembolism (1)
Cystectomy (1)
Biliary Tract (1)
Chemistry (1)
Response Evaluation Criteria in Solid Tumors (1)
Pre-Study Form (1)
Off-Treatment (1)
Non Small Cell Lung Cancer (1)
Cystoscopy (1)
Hematologic Tests (1)

Show more Keywords

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

72 Search results.

A Phase II Study of AZD4877 (a Novel Anti-mitotic DRKS00004052 - Eligibility Bladder Cancer NCT00661609

- 9/27/21 - 1 form, 2 itemgroups, 8 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

The purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth), can reduce tumor sizes in patients with bladder cancer see http://clinicaltrials.gov/ct2/show/study/NCT00661609

Swedish Bladder Cancer Registry - Cystectomy - Follow-Up

- 9/27/21 - 1 form, 5 itemgroups, 106 items, 2 languages

Itemgroups: General Information,Preoperative Data,Perioperative Data,Postoperative Data,Complications and Reoperations

Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ Cystectomy - Follow-Up

CALGB: 90104 SPECIMEN SUBMISSION FORM NCT00014534

- 9/20/21 - 1 form, 3 itemgroups, 23 items, 1 language

Itemgroups: Header,Patient demographics,SPECIMEN SUBMISSION

CALGB: 90104 SPECIMEN SUBMISSION FORM NCT00014534 Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E5F4A97F-274E-398C-E034-0003BA3F9857

NCI COOPERATIVE GROUP Patient Information FORM (CALGB-90104)

- 9/20/21 - 1 form, 6 itemgroups, 41 items, 1 language

Itemgroups: MSKCC 00-138; CALGB-90104; ECOG,Protocol Administration,Patient Demographics / Pre-Treatment Characteristics,Certification of Eligibility,Protocol Design,Initial Patient Consent for Specimen Use

NCI COOPERATIVE GROUP Patient Information FORM (CALGB-90104) Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A9BED937-4416-2507-E034-0003BA12F5E7

Bladder Cancer NCT00445601 On-Study - S0337 Cystoscopy and Urine Markers Form - 2389143v1.0 - S0337 Cystoscopy and Urine Markers Form

- 9/20/21 - 1 form, 4 itemgroups, 25 items, 1 language

Itemgroups: Header,Urine Markers,Cytoscopy,Comments

S0337 Cystoscopy and Urine Markers Form Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FE26193B-C3C0-4C67-E034-0003BA3F9857

Eligibility DRKS00004052 NCT00661609 Bladder Cancer - Eligibility Advanced Bladder Cancer NCT00661609

- 9/17/21 - 1 form, 2 itemgroups, 8 items, 1 language

Itemgroups: Inclusion criteria,Exclusion criteria

Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

Bladder Cancer NCT00014534 Registration - CALGB 90104 Registration Worksheet-Rev - 2169333v3.0 - CALGB 90104 Registration Worksheet-Rev

- 9/17/21 - 1 form, 2 itemgroups, 34 items, 1 language

Itemgroups: Initial Patient Consent for Specimen Use,CCRR MODULE

CALGB 90104 Registration Worksheet-Rev Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B0F83-6C73-6D73-E034-0003BA12F5E7

Bladder Cancer NCT00942331 Registration - CALGB 90601 Registration Worksheet - 2848728v1.0 - CALGB 90601 Registration Worksheet

- 9/17/21 - 1 form, 10 itemgroups, 46 items, 1 language

Itemgroups: Header Module,Protocol Administration,Patient Demographics/Pre-Treatment Characteristics1,Patient Demographics/Pre-Treatment Characteristics2,Patient Demographics/Pre-Treatment Characteristics3,Certification Of Eligibility,Protocol Design,Initial Patient Consent For Specimen Use,Prior Cancer Therapies,Registration Information

CALGB 90601 Registration Worksheet Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=653F1390-699C-B455-E040-BB89AD4361B9

Eligibility Solid Tumors, NSCLC, Biliary and Bladder Cancer NCT02240238

- 10/1/20 - 1 form, 2 itemgroups, 9 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02240238

Eligibility Bladder Cancer NCT01954173

- 8/18/19 - 1 form, 2 itemgroups, 16 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Adjuvant Radiation for High Risk Bladder Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01954173

Eligibility Locally Advanced or Metastatic Urothelial Cell Carcinoma NCT02401542

- 4/29/19 - 1 form, 1 itemgroup, 10 items, 1 language

Itemgroup: Criteria

A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02401542

Swedish Bladder Cancer Registry - 5-Year Follow-Up

- 11/19/17 - 1 form, 2 itemgroups, 15 items, 2 languages

Itemgroups: General Information,Follow-Up

Swedish Bladder Cancer Registry Healthcare Quality http://www.cancercentrum.se/vast/cancerdiagnoser/urinvagar/urinblase--och-urinvagscancer/kvalitetsregister/dokument/ 5-year Follow-Up

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.